APA

Maura F., Petljak M., Lionetti M., Cifola I., Liang W., Pinatel E., Alexandrov L. B., Fullam A., Martincorena I., Dawson K. J., Angelopoulos N., Samur M. K., Szalat R., Zamora J., Tarpey P., Davies H., Corradini P., Anderson K. C., Minvielle S., Neri A., Avet-Loiseau H., Keats J., Campbell P. J., Munshi N. C. & Bolli N. (20190219). Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines. : Leukemia.

Chicago

Maura F, Petljak M, Lionetti M, Cifola I, Liang W, Pinatel E, Alexandrov L B, Fullam A, Martincorena I, Dawson K J, Angelopoulos N, Samur M K, Szalat R, Zamora J, Tarpey P, Davies H, Corradini P, Anderson K C, Minvielle S, Neri A, Avet-Loiseau H, Keats J, Campbell P J, Munshi N C and Bolli N. 20190219. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines. : Leukemia.

Harvard

Maura F., Petljak M., Lionetti M., Cifola I., Liang W., Pinatel E., Alexandrov L. B., Fullam A., Martincorena I., Dawson K. J., Angelopoulos N., Samur M. K., Szalat R., Zamora J., Tarpey P., Davies H., Corradini P., Anderson K. C., Minvielle S., Neri A., Avet-Loiseau H., Keats J., Campbell P. J., Munshi N. C. and Bolli N. (20190219). Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines. : Leukemia.

MLA

Maura F, Petljak M, Lionetti M, Cifola I, Liang W, Pinatel E, Alexandrov L B, Fullam A, Martincorena I, Dawson K J, Angelopoulos N, Samur M K, Szalat R, Zamora J, Tarpey P, Davies H, Corradini P, Anderson K C, Minvielle S, Neri A, Avet-Loiseau H, Keats J, Campbell P J, Munshi N C and Bolli N. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines. : Leukemia. 20190219.